GO
Loading...

Enter multiple symbols separated by commas

Valeant Pharmaceuticals International Inc

More

  • The company said it expects 2015 revenue of $10.4- $10.6 billion, up from its previous estimate of $9.2- $9.3 billion. Valeant, which lost a bid for Botox maker Allergan Inc in November, said sales from the United States rose to $1.40 billion in the first quarter ended March 31. Net income attributable to shareholders was $73.7 million, or 21 cents per share, in the...

  • Valeant raises outlook after completing purchase of Salix Wednesday, 29 Apr 2015 | 6:43 AM ET

    LAVAL, Quebec— Valeant Pharmaceuticals International Inc. said Wednesday it turned a profit in the first quarter, and the Canadian drugmaker raised its forecasts for the year after completing more acquisitions. The company reported a profit of $73.7 million, or 21 cents per share, after it lost $22.6 million, or 7 cents per share, a year ago. The Laval, Quebec- based...

  • Valeant Pharma posts profit, says CFO to step down Wednesday, 29 Apr 2015 | 6:28 AM ET

    April 29- Canadian drugmaker Valeant Pharmaceuticals International Inc reported a quarterly profit, compared with a year-ago loss, driven by higher demand in the United States. The company also said Chief Financial Officer Howard Schiller would step down. Net income attributable to shareholders was $73.7 million, or 21 cents per share, in the first quarter...

  • April 21- Some of the top investors at Mylan NV, including Paulson& Co, are encouraging its board of directors to consider a takeover proposal from rival Teva Pharmaceutical Industries Inc, according to people familiar with the matter. Teva unveiled an unsolicited $40 billion takeover proposal on Tuesday for the Canonsburg, Pennsylvania- based company.

  • Billionaire John Paulson up 14% on M&A bets Tuesday, 31 Mar 2015 | 7:20 AM ET
    John Pauslon

    Billionaire investor John Paulson is starting off 2015 with a bang — thanks to a heated merger market.

  • Iron ore gloom chills Fortescue bond sale Thursday, 19 Mar 2015 | 4:37 AM ET

    NEW YORK/ MELBOURNE, March 19- A treacherous snowstorm snarled flights the day Fortescue Metals Group's CFO touched down in New York on a mission to tap the loan market for $2.5 billion to help the world's no.4 iron ore miner ride out collapsing iron ore prices. The timing was terrible- as Stephen Pearce battled through the frigid Manhattan weather, another squall...

  • Junk bond market defies skeptics Wednesday, 18 Mar 2015 | 11:28 AM ET
    Traders work on the floor of the New York Stock Exchange.

    There has been no sting in the tail for investors willing to bet on US high-yield bonds during 2015, the Financial Times reports.

  • After-hours buzz: Jumei, American Air & more Monday, 16 Mar 2015 | 5:46 PM ET
    Traders on the floor of the New York Stock Exchange.

    Take a look at some of Monday's after-hours buzz: Jumei, American Air & more.

  • March 16- U.S. stocks rallied on Monday as the U.S. dollar eased back from its recent peak and worries eased about the timing of a Federal Reserve interest rate hike. The S&P healthcare sector led gains in the S&P 500. It jumped 2.2 percent, helped by a 5.7 percent price increase in shares of Amgen to $163.03, following promising data in studies of a new class of...

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed higher as investors cheered a pause in the dollar rally and eyed renewed weakness in oil prices ahead of Wednesday's Fed meeting.

  • "It's just a little bit of relief from last week's selloff," said Joseph Benanti, managing director, sales and trading of Rosenblatt Securities in New York. The S&P healthcare sector was up 1.9 percent, helped by a 3.6 percent price increase in shares of Amgen to $159.73, following promising data in studies of a new class of cholesterol-reducing drugs.

  • *Empire State manufacturing data miss estimates. "It's just a little bit of relief from last week's selloff," said Joseph Benanti, managing director, sales and trading of Rosenblatt Securities in New York. Until Fed Chair Janet Yellen's statement on Wednesday afternoon, Benanti is expecting light volume.

  • *Empire State manufacturing data misses estimates. March 16- U.S. stocks opened higher Monday and the benchmark S&P 500 rebounded after three weeks of losses as the euro strengthened against the dollar, easing some concerns over the impact of a robust greenback on corporate earnings. A recovery in the euro was reassuring investors, said Nick Colas, chief market...

  • US STOCKS-Wall St futures rise as euro recovers Monday, 16 Mar 2015 | 9:02 AM ET

    *Empire State manufacturing data miss estimates. March 16- U.S. stock index futures were up on Monday, putting the benchmark S&P 500 on track for a rebound after three weeks of losses, as currency markets helped reassure U.S. investors concerned about how a strong dollar would hurt earnings. A recovery in the euro was reassuring investors as a rapidly rising U.S....

  • BUZZ-SALIX PHARMACEUTICALS PLC: VALEANT RAISES ALL-CASH OFFER@** American drugmaker's shares up 2 pct at $173. **Canadian drugmaker Valeant Pharmaceuticals International Inc raised its offer to buy Salix to $173 from $158 in cash. **Sources told Reuters on Friday Valeant was working with its top shareholders on plans to raise its offer for Salix, sending Dublin-...

  • Valeant, Salix agree to cash deal of $173 a share Monday, 16 Mar 2015 | 7:56 AM ET
    Valeant Pharmaceuticals sign at the company's headquarters in Mississauga, Ontario.

    Valeant Pharmaceuticals agreed to buy Salix Pharmaceuticals for $173 per share Monday morning.

  • Valeant won't overpay for Salix: Bill Ackman Friday, 13 Mar 2015 | 12:33 PM ET
    Valeant Pharmaceuticals International’s headquarters in Mississauga, Ontario, Canada, is shown in this March 30, 2011 photo.

    Valeant chief Michael Pearson won't pay too much for Salix, which earlier this week received a competing offer from Endo, Bill Ackman tells CNBC.

  • Traders on the floor of the New York Stock Exchange.

    U.S. stocks closed mildly lower on amid continued concern over dollar gains and the timing of a Fed interest rate hike.

  • Early movers: QCOM, CS, URBN, SWKS, PG & more Tuesday, 10 Mar 2015 | 7:49 AM ET

    Some of the names on the move ahead of the open.

  • After-hours buzz: Urban Outfitters, Casey's & more Monday, 9 Mar 2015 | 5:19 PM ET
    Traders on the floor of the New York Stock Exchange, December 1, 2014.

    Check out the companies making headlines after the bell Monday: Urban Outfitters, Qualcomm, Casey's & more.